Nasdaq Rises Above 6,000 For The First Time Ever
Apr 25, 2017Jeremy Parkinson0
Another day, another market record, this time in nice round numbers, as the Nasdaq hits new all time highs, rising above 6,000 for the first time ever … … driven by the familiar five tech giants Amazon, Apple, Facebook, Google, Microsoft, which together now account for over 10% of the total US market cap.
King Dollar; Attempting To Break 3-Year Rising Support
Apr 25, 2017Jeremy Parkinson0
Below looks at a long-term chart of the US Dollar, that was shared on 12/30/16. This chart highlighted that King Dollar was facing two long term resistance lines, at the 104 zone. (See Post Here). Joe Friday was pointing out this was a rare test of resistance and could be the price zone, where a major top could […]
Eli Lilly And Co. Q1 Profit & Revenue Beat The Street
Apr 25, 2017Jeremy Parkinson0
Eli Lilly and Co. (NYSE:LLY) early Tuesday posted better than expected first quarter earnings results and backed its full-year outlook, as its new product launches are going mostly as expected.
T. Rowe Price (TROW) Q1 Earnings Lag On High Costs
Apr 25, 2017Jeremy Parkinson0
Have you been eager to see how T. Rowe Price Group, Inc. (TROW – Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this MD-based popular asset management firm’s earnings release this morning: An Earnings Miss T. Rowe Price came out with adjusted earnings per share of $1.18, lagging […]
Silver Giving Way?
Apr 25, 2017Jeremy Parkinson0
It is my only short position now, having taken losses on a couple market shorts (partially hedging longs) and a gain on crude oil (just because I was straight out bearish on oil). But silver told me to keep holding short (I increased the short last week) and so far that is working out. SLV […]
Biotech Digest – JAZZ Reports Positive Results, CTSO Inks New Contract, AMGN Forges Collaboration
Apr 25, 2017Jeremy Parkinson0
Top Pick of the Day: CAPR Capricor Therapeutics (CAPR) announced encouraging six-month results in a Phase 1/2 clinical trial, HOPE, evaluating lead product candidate CAP-1002 in Duchenne muscular dystrophy (DMD) patients at least 12 years old with heart disease secondary to DMD. HOPE randomized 25 subjects to receive either a single dose of CAP-1002 (n=13) […]
LePen Euro Frexit Panic Over – “For Now”
Apr 25, 2017Jeremy Parkinson0
Written by John Stepek, Editor of Money Week OK, drama’s over. The French election has turned out pretty much exactly as expected. For all that some of the papers are leading with “French revolution” headlines, the reality is that a face-off between the right-wing Marine Le Pen of the Front National and independent/socialist candidate Emmanuel […]
Netflix, Inc. Inks Licensing Deal With Beijing-Based Video Service IQiyi To Bring Its Content To China
Apr 25, 2017Jeremy Parkinson0
Netflix, Inc. (Nasdaq:NFLX) has been trying for years to bring its namesake streaming media service to China, but has faced stiff opposition from regulators at every turn so now, the company is taking a new approach that could fall under the old cliche “If you can’t beat ’em, join ’em.” Written by StockNews.com That’s because […]
Express Scripts Holding Shares Crash On News Of Company Losing Its Biggest Client Anthem
Apr 25, 2017Jeremy Parkinson0
Express Scripts Holding Company (ESRX), a global pharmacy benefit management (PBM) company yesterday announced that they will be losing their biggest customer Anthem. Express announced that Anthem their biggest customer does not plan on extending their contract when it expires in 2019. Anthem has sued Express Scripts in March of last year stating they were […]
The Stock Whisper Of The Day: AA, AKS, FCX, SPY, USO
Apr 25, 2017Jeremy Parkinson0
Hot stocks of the day: AA, AKS, FCX, SPY, USO Video length: 00:05:30